Triazine-thiazolidone compound as well as preparation method and application thereof

Triazine-thiazolidone compound as well as preparation method and application thereof

The invention belongs to the field of medicinal chemistry, and relates to a triazine-thiazolidone compound as well as a preparation method and application thereof. The structural formula of the triazine-thiazolidinone compound is shown in the specification, wherein R1 is any one of alkyl, aryl or he...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DIAO XIAOQIONG, DU JIANGFENG, SUN KAI, LI JIAO
Format: Patent
Sprache:chi ; eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DIAO XIAOQIONG
DU JIANGFENG
SUN KAI
LI JIAO
description The invention belongs to the field of medicinal chemistry, and relates to a triazine-thiazolidone compound as well as a preparation method and application thereof. The structural formula of the triazine-thiazolidinone compound is shown in the specification, wherein R1 is any one of alkyl, aryl or heteroaryl, and R2 is alkyl or aryl; the pharmaceutically acceptable salt is the acid salt of the compound, and the acid is any one of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, boric acid, methanesulfonic acid, p-toluenesulfonic acid, naphthalene sulfonic acid, benzenesulfonic acid, citric acid, lactic acid, pyruvic acid, tartaric acid, acetic acid, trifluoroacetic acid, maleic acid, succinic acid, mandelic acid, fumaric acid, salicylic acid or phenylacetic acid. The triazine-thiazolidone compound provided by the invention is novel in structure, has a very good inhibition effect on glucose transporter 1 (GLUT1), has an inhibition effect superior to that of a positive control compound BAY-87
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116655621A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116655621A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116655621A3</originalsourceid><addsrcrecordid>eNqNirEKwjAURbs4iPoP8QM6RGl2KYqTU_bySG9JIM17JBHBr7dFP8DpXO4528baHOgdEtrql8ExjJygHM_CzzQqKuqFGFdKhlCmGjipGdXzYtdCJAb3vatHBk_7ZjNRLDj8uGuOt6vt7y2EBxQhh4Q69A-tjek6c9KX8z_NB_UEOXU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Triazine-thiazolidone compound as well as preparation method and application thereof</title><source>esp@cenet</source><creator>DIAO XIAOQIONG ; DU JIANGFENG ; SUN KAI ; LI JIAO</creator><creatorcontrib>DIAO XIAOQIONG ; DU JIANGFENG ; SUN KAI ; LI JIAO</creatorcontrib><description>The invention belongs to the field of medicinal chemistry, and relates to a triazine-thiazolidone compound as well as a preparation method and application thereof. The structural formula of the triazine-thiazolidinone compound is shown in the specification, wherein R1 is any one of alkyl, aryl or heteroaryl, and R2 is alkyl or aryl; the pharmaceutically acceptable salt is the acid salt of the compound, and the acid is any one of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, boric acid, methanesulfonic acid, p-toluenesulfonic acid, naphthalene sulfonic acid, benzenesulfonic acid, citric acid, lactic acid, pyruvic acid, tartaric acid, acetic acid, trifluoroacetic acid, maleic acid, succinic acid, mandelic acid, fumaric acid, salicylic acid or phenylacetic acid. The triazine-thiazolidone compound provided by the invention is novel in structure, has a very good inhibition effect on glucose transporter 1 (GLUT1), has an inhibition effect superior to that of a positive control compound BAY-87</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230829&amp;DB=EPODOC&amp;CC=CN&amp;NR=116655621A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230829&amp;DB=EPODOC&amp;CC=CN&amp;NR=116655621A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DIAO XIAOQIONG</creatorcontrib><creatorcontrib>DU JIANGFENG</creatorcontrib><creatorcontrib>SUN KAI</creatorcontrib><creatorcontrib>LI JIAO</creatorcontrib><title>Triazine-thiazolidone compound as well as preparation method and application thereof</title><description>The invention belongs to the field of medicinal chemistry, and relates to a triazine-thiazolidone compound as well as a preparation method and application thereof. The structural formula of the triazine-thiazolidinone compound is shown in the specification, wherein R1 is any one of alkyl, aryl or heteroaryl, and R2 is alkyl or aryl; the pharmaceutically acceptable salt is the acid salt of the compound, and the acid is any one of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, boric acid, methanesulfonic acid, p-toluenesulfonic acid, naphthalene sulfonic acid, benzenesulfonic acid, citric acid, lactic acid, pyruvic acid, tartaric acid, acetic acid, trifluoroacetic acid, maleic acid, succinic acid, mandelic acid, fumaric acid, salicylic acid or phenylacetic acid. The triazine-thiazolidone compound provided by the invention is novel in structure, has a very good inhibition effect on glucose transporter 1 (GLUT1), has an inhibition effect superior to that of a positive control compound BAY-87</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEKwjAURbs4iPoP8QM6RGl2KYqTU_bySG9JIM17JBHBr7dFP8DpXO4528baHOgdEtrql8ExjJygHM_CzzQqKuqFGFdKhlCmGjipGdXzYtdCJAb3vatHBk_7ZjNRLDj8uGuOt6vt7y2EBxQhh4Q69A-tjek6c9KX8z_NB_UEOXU</recordid><startdate>20230829</startdate><enddate>20230829</enddate><creator>DIAO XIAOQIONG</creator><creator>DU JIANGFENG</creator><creator>SUN KAI</creator><creator>LI JIAO</creator><scope>EVB</scope></search><sort><creationdate>20230829</creationdate><title>Triazine-thiazolidone compound as well as preparation method and application thereof</title><author>DIAO XIAOQIONG ; DU JIANGFENG ; SUN KAI ; LI JIAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116655621A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DIAO XIAOQIONG</creatorcontrib><creatorcontrib>DU JIANGFENG</creatorcontrib><creatorcontrib>SUN KAI</creatorcontrib><creatorcontrib>LI JIAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DIAO XIAOQIONG</au><au>DU JIANGFENG</au><au>SUN KAI</au><au>LI JIAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Triazine-thiazolidone compound as well as preparation method and application thereof</title><date>2023-08-29</date><risdate>2023</risdate><abstract>The invention belongs to the field of medicinal chemistry, and relates to a triazine-thiazolidone compound as well as a preparation method and application thereof. The structural formula of the triazine-thiazolidinone compound is shown in the specification, wherein R1 is any one of alkyl, aryl or heteroaryl, and R2 is alkyl or aryl; the pharmaceutically acceptable salt is the acid salt of the compound, and the acid is any one of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, boric acid, methanesulfonic acid, p-toluenesulfonic acid, naphthalene sulfonic acid, benzenesulfonic acid, citric acid, lactic acid, pyruvic acid, tartaric acid, acetic acid, trifluoroacetic acid, maleic acid, succinic acid, mandelic acid, fumaric acid, salicylic acid or phenylacetic acid. The triazine-thiazolidone compound provided by the invention is novel in structure, has a very good inhibition effect on glucose transporter 1 (GLUT1), has an inhibition effect superior to that of a positive control compound BAY-87</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN116655621A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Triazine-thiazolidone compound as well as preparation method and application thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A53%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DIAO%20XIAOQIONG&rft.date=2023-08-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116655621A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true